Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne T Reutens

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Medical Clinics of North America|January 8, 2013
Epidemiology of diabetic kidney diseaseAnne T Reutens
Nature Reviews. Endocrinology|July 27, 2010
Diabetes: Individualized therapy for diabetes mellitus--just a promise?Anne T Reutens
Contributions to Nephrology|June 11, 2011
Epidemiology of diabetic nephropathyAnne T Reutens, Robert C Atkins
The International Journal of Biochemistry & Cell Biology|July 20, 2002
Endophilin-1: a multifunctional proteinAnne T Reutens, C Glenn Begley
Diabetes Technology & Therapeutics|November 30, 2013
A pilot study to examine the tolerability and device preference in type 1 diabetes of insulin aspart administered by InsuJet compared with subcutaneous injectionAnne T Reutens, Beverley Balkau, Neale Cohen
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 8, 2013
The association between cystatin C and incident type 2 diabetes is related to central adiposityAnne T Reutens, Fabrice Bonnet, Olivier Lantieri, et al.
Clinical Endocrinology|February 21, 2004
Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal womenAilish G Nugent, Kin-Chuen Leung, David Sullivan, et al.
Nephrology (Carlton, Vic.)|March 20, 2013
Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockersSara E Ivory, David K Packham, Anne T Reutens, et al.
Diabetes, Obesity & Metabolism|September 12, 2018
Acute metabolic and cardiovascular effects of mirabegron in healthy individualsRebecca K C Loh, Melissa F Formosa, Andre La Gerche, et al.
JACC. Advances|November 8, 2025
Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Outflows in Type 2 DiabetesAnne T Reutens, Dulari Hakamuwa Lekamlage, Agus Salim, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Medical Clinics of North America|January 8, 2013
Epidemiology of diabetic kidney diseaseAnne T Reutens
Nature Reviews. Endocrinology|July 27, 2010
Diabetes: Individualized therapy for diabetes mellitus--just a promise?Anne T Reutens
Contributions to Nephrology|June 11, 2011
Epidemiology of diabetic nephropathyAnne T Reutens, Robert C Atkins
The International Journal of Biochemistry & Cell Biology|July 20, 2002
Endophilin-1: a multifunctional proteinAnne T Reutens, C Glenn Begley
Diabetes Technology & Therapeutics|November 30, 2013
A pilot study to examine the tolerability and device preference in type 1 diabetes of insulin aspart administered by InsuJet compared with subcutaneous injectionAnne T Reutens, Beverley Balkau, Neale Cohen
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 8, 2013
The association between cystatin C and incident type 2 diabetes is related to central adiposityAnne T Reutens, Fabrice Bonnet, Olivier Lantieri, et al.
Clinical Endocrinology|February 21, 2004
Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal womenAilish G Nugent, Kin-Chuen Leung, David Sullivan, et al.
Nephrology (Carlton, Vic.)|March 20, 2013
Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockersSara E Ivory, David K Packham, Anne T Reutens, et al.
Diabetes, Obesity & Metabolism|September 12, 2018
Acute metabolic and cardiovascular effects of mirabegron in healthy individualsRebecca K C Loh, Melissa F Formosa, Andre La Gerche, et al.
JACC. Advances|November 8, 2025
Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Outflows in Type 2 DiabetesAnne T Reutens, Dulari Hakamuwa Lekamlage, Agus Salim, et al.
Pageof 3